Facebook
Twitter
LinkedIn
Forward5th Binaytara Precision Oncology Summit: Current Standards and Emerging Therapies
Overview
The 5th Binaytara Precision Oncology Summit is an annual 2-day CME-accredited national conference that offers an unparalleled opportunity for oncology professionals to delve into the latest advancements, innovations, and practices in precision oncology. The theme for this year's summit, "Current Standards and Emerging Therapies," highlights the conference's commitment to providing a comprehensive overview of the field, including in-depth discussions on the latest developments in precision oncology, alongside a thorough examination of established treatment protocols. Focus on actionable mutations ensures that the presented information translates directly into improved patient care.
The summit features didactics, panel discussions, interactive case studies, and scientific abstract presentations.
This conference will augment healthcare providers' foundation of knowledge and clinical competence in several areas, including:
- Integrating different platforms available for testing actionable molecular alterations to identify targeted therapy options.
- Current and evolving paradigms in precision oncology approach for management of common malignancies.
- Trends, challenges, controversies, and cost-considerations of precision oncology approaches and targeted therapies.
Target Audience
- Hematologists/Oncologists
- Oncology Nurse Practitioners
- Oncology Pharmacists
- Oncology Physician Assistants
- Oncology Fellows/Residents
- Oncology Nurses
- Researchers and others involved in the care of cancer patients
Organizing Committee
Program Director:
Binay Shah, MD, MHA - Binaytara
Conference Chair:
Mark Pegram, MD - Stanford University
Learning Objectives
Upon successful completion of this educational activity on precision oncology, participants will be able to:
- Identify frequent molecular abnormalities across several common malignancies and understand the appropriate timing of testing to detect these abnormalities.
- Interpret results of next-generation sequencing and other biomarkers predictive of response to targeted therapies and recognize the challenges involved.
- Explain the role, including advantages and disadvantages, of different testing methodologies available for a selection of targeted therapies.
- Plan optimal molecular-targeted treatment strategies for the treatment of cancer.
- Outline emerging research, the mechanism of action, and the role of novel molecular-targeted therapies in a clinical investigation for cancer patients.
GLOBAL ONCOLOGY PROJECT
Click this link to learn more about our ongoing project building a 200-bed cancer hospital in Nepal: https://binayfoundation.org/cancer-hospital/
Program
DAY 1 - OCTOBER 24th, 2025
All times listed in Pacific Daylight Time (PDT).
09:00 AM – 10:00 AM Registration, Breakfast, and Exhibits
10:00 AM – 10:15 AM Welcome
10:15 AM – 11:00 AM Plenary Speech - Advances in Genomic Medicine
11:00 AM – 12:00 PM Session 1: Genomic Profiling in Cancer
Session Chair:
11:00 AM – 11:20 AM Keynote Speech: Germ Line Testing in Cancer Treatment: From Sequencing to Clinical Application -
11:20 AM – 12:00 PM Panel Discussion
12:00 PM – 01:00 PM Lunch & Exhibits
01:00 PM – 02:00 PM Session 2: Pathway-Based Targeted Therapies in Oncology
Session Chair:
01:00 PM – 01:20 PM Keynote Speech
01:20 PM – 02:00 PM Case-Based Discussion
02:00 PM – 03:00 PM Session 3: Molecular Tumor Board 1: Interesting and Challenging Cases in Precision Oncology
Session Chair:
Case Presenters:
03:00 PM – 03:30 PM Break & Exhibits
03:30 PM – 04:00 PM Session 4: Liquid Biopsy and Non-Invasive Testing
Session Chair:
04:00 PM – 04:30 PM Session 5: Roundtable Discussion: Ethical Challenges in Precision Oncology
Session Chair:
Panelists:
04:30 PM – 05:15 PM Session 6: Personalized Cancer Vaccines in Immuno-oncology
Session Chair:
04:30 PM – 04:45 PM Development of Personalized Cancer Vaccines and Immunotherapy -
04:45 PM – 05:15 PM Panel Discussion
05:15 PM Adjourn
05:15 PM – 06:15 PM Networking Reception
DAY 2 - OCTOBER 25th, 2025
07:00 AM – 08:00 AM Registration, Breakfast, and Exhibits
08:00 AM – 09:15 AM Session 6: Artificial Intelligence in Precision Oncology
Session Chair:
09:15 AM – 10:15 AM Session 7: Oral Abstract Presentations
Session Chair:
10:15 AM – 10:45 AM Break & Exhibits
10:45 AM – 11:15 AM Binaytara’s Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA
11:15 AM – 12:15 PM Session 8: Panel Discussion: Practical Challenges and Barriers in Clinical Adoption of Precision Oncology
Session Chair:
Panelists:
12:15 PM – 01:15 PM Lunch & Exhibits
01:15 PM – 02:45 PM Session 9: Molecular Tumor Board 2: Interesting and Challenging Cases in Precision Oncology
Session Chair:
Case Presenters:
02:45 PM – 03:00 PM Break & Exhibits
03:00 PM – 04:00 PM Session 10: The Future of Precision Oncology: Biomarker Discovery and Validation
Session Chair:
03:00 PM – 03:20 PM Keynote Speech
03:20 PM – 04:00 PM Panel Discussion
04:00 PM – 04:45 PM Session 11: Roundtable Discussion: The Future of Precision Oncology
Session Chair:
Panelists:
04:45 PM – 05:00 PM Closing Remarks and Thank You
05:00 PM Adjourn
Faculty
IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:
All conflict of interest has been identified and mitigated for individuals in control of contents.
PLANNING COMMITTEE DISCLOSURE STATEMENT:
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
Accreditation
Available Credit
- 0.00 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 0.00 ACPE Pharmacy
The Binaytara Foundation is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The ACPE Universal Activity Number assigned to the activity is
Participants must pass the post-test, complete course evaluation, and provide their NABP e-Profile ID number (ePID) and Date of Birth (MMDD) to Binaytara Foundation within 30-days of participating in the activity. Participants who do not complete these requirements within 30-days of participating in the Live activity will not be awarded the CEUs.
The Binaytara foundation may distribute a participation certificate containing information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®.
After CPE units are processed by ACPE and NABP, pharmacists and pharmacy technicians will be able to login to a comprehensive electronic profile to access information about their completed CPE and Certificate Programs.
- 0.00 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 0.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 0.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 0.00 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 0.00 Contact Hours.
Exhibitors
If you are interested in exhibiting at this meeting or purchasing a badge with your company at our discounted rate for exhibitors, please visit our exhibit page here - https://www.sponsorships.binayfoundation.org/Exhibit
Register/Take course
Price
POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE:
All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place.
The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference. The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees.
If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.
Violating this policy will result in a fine equivalent to a general display fee for that conference.
NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
- If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
CANCELLATION POLICY
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
- No refunds will be issued if registration is canceled after that date.
No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.